In this publication, they confirmed the efficacy of GLP-1 in managing BED, revealing that patients receiving GLP-1 agonists experienced greater weight loss compared to controls.
There has been substantial interest in the development of GLP-1 drugs and optimism about their public health effects. But some worrisome signals related to disordered eating have emerged.
Learn about GLP-1 medications (i.e., Mounjaro, Ozempic, Wegovy etc.) and eating disorders. Visit the National Eating Disorders Association.
This particular example perfectly highlights why Glp-1 Agonists For Inner Critic Eating is so captivating.
Glucagon-like peptide-1 receptor agonists (GLP-1As) are being used as approved or off-label treatments for weight loss. As such, there has been increasing concern about the potential for GLP-1As to impact eating disorder (ED) symptomatology.
For those with eating disorders, GLP-1s can be tempting as a form of restriction or compensatory behavior and may be misused. Theres no protocol in place to screen for eating disorders prior to prescribing GLP-1 receptor agonists, says Dr. Boswell.
